Epione Medicine ApS — Credit Rating and Financial Key Figures
CVR number: 41812052
Kanalholmen 14 L, 2650 Hvidovre
E.Johannsen@EpioneMedicine.com
tel: 71809864
Epionemedicine.com
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | - 336.92 | 2 307.03 | 2 580.42 | 31 344.46 |
Employee benefit expenses | -9.21 | - 686.09 | -2 448.40 | -5 338.97 |
Total depreciation | -58.05 | - 247.25 | - 395.88 | - 529.81 |
EBIT | - 404.17 | 1 373.70 | - 263.86 | 25 475.68 |
Other financial income | 2.71 | 7.62 | 2.47 | |
Other financial expenses | -63.16 | - 340.82 | - 549.78 | -1 007.02 |
Pre-tax profit | - 464.62 | 1 040.50 | - 813.63 | 24 471.14 |
Income taxes | 101.86 | - 230.38 | 165.00 | -5 425.92 |
Net earnings | - 362.76 | 810.11 | - 648.63 | 19 045.22 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Development expenditure | 192.39 | |||
Intangible rights | 271.85 | 447.55 | 714.94 | 1 322.43 |
Intangible assets total | 271.85 | 447.55 | 714.94 | 1 514.82 |
Buildings | 10.80 | 265.48 | ||
Machinery and equipment | 40.47 | 105.75 | 360.54 | 617.93 |
Tangible assets total | 51.28 | 105.75 | 360.54 | 883.41 |
Investments total | 65.55 | 30.55 | 30.55 | 134.18 |
Long term receivables total | ||||
Raw materials and consumables | 158.01 | 607.02 | 1 993.17 | 4 420.52 |
Finished products/goods | 303.93 | 599.78 | 1 070.99 | 899.67 |
Advance payments | 108.26 | 1 078.75 | ||
Inventories total | 461.94 | 1 206.80 | 3 172.41 | 6 398.94 |
Current trade debtors | 206.79 | 660.29 | 4 275.76 | 39 191.15 |
Prepayments and accrued income | 66.50 | 183.01 | 129.10 | |
Current other receivables | 31.34 | |||
Current deferred tax assets | 101.86 | 75.00 | ||
Short term receivables total | 406.49 | 843.30 | 4 350.76 | 39 320.25 |
Cash and bank deposits | 1 690.27 | |||
Cash and cash equivalents | 1 690.27 | |||
Balance sheet total (assets) | 1 257.10 | 4 324.22 | 8 629.21 | 48 251.60 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Share capital | 353.00 | 353.00 | 353.00 | 353.00 |
Share premium account | 27.01 | |||
Shares repurchased | 150.00 | 18 500.00 | ||
Other reserves | 150.06 | |||
Retained earnings | - 485.76 | 324.36 | -18 974.34 | |
Profit of the financial year | - 362.76 | 810.11 | - 648.63 | 19 045.22 |
Shareholders equity total | 17.24 | 827.36 | 28.72 | 19 073.94 |
Provisions | 90.00 | 802.92 | ||
Non-current other liabilities | 769.19 | |||
Non-current deferred tax liabilities | 621.81 | 1 104.05 | 1 243.35 | |
Non-current liabilities total | 769.19 | 621.81 | 1 104.05 | 1 243.35 |
Current loans from credit institutions | 167.79 | 100.00 | 2 798.56 | 2 652.60 |
Current trade creditors | 106.16 | 1 125.78 | 1 851.67 | 8 630.96 |
Current owed to group member | 7.20 | |||
Short-term deferred tax liabilities | 38.52 | 4 878.81 | ||
Other non-interest bearing current liabilities | 196.71 | 1 520.75 | 2 846.21 | 10 961.82 |
Current liabilities total | 470.66 | 2 785.05 | 7 496.44 | 27 131.38 |
Balance sheet total (liabilities) | 1 257.10 | 4 324.22 | 8 629.21 | 48 251.60 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.